Ledger.Open graph →
SEC Form D · filed September 5, 2018

Principia Biopharma Inc

Offering
$50.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

R. S. Doyle · Wexford, PAExec · DirectorMichael S. Dignazio · Wexford, PADirectorJill F. Schiaparelli · Wexford, PADirectorWilliam P. Malloy · Wexford, PADirectorMary Del Brady · Wexford, PADirectorAlan Colowick · Palo Alto, CADirectorDaniel Becker · San Francisco, CADirectorJan Berkow · Wexford, PAExec · DirectorChang Hoon Choi · Jung-gu, Seoul, M5DirectorJohn Hathaway · Pittsburgh, PADirectorDavid Rodriguez-Fraile · New York, NYDirectorGreg Elmlinger · San Francisco, CADirectorAlan Colowick · San Diego, CADirectorDaniel Becker · San Diego, CADirectorLewis J. Shuster · Vancouver, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗